Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Hyperfine, Inc. - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
HYPR
Nasdaq
3840
hyperfine.io
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Hyperfine, Inc.
Hyperfine Announces Publication of Breakthrough Clinical Data Demonstrating the Swoop® System’s Enhanced Stroke Detection Capabilities
- Jan 27th, 2026 6:15 am
Investors in Hyperfine (NASDAQ:HYPR) have unfortunately lost 87% over the last five years
- Jan 22nd, 2026 4:22 am
Hyperfine Announces NEURO PMR Study Results Showing High Diagnostic Value and Superior Patient Experience in Neurology Clinics
- Jan 20th, 2026 6:15 am
Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents
- Jan 15th, 2026 6:15 am
Hyperfine Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results
- Jan 12th, 2026 6:15 am
Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors
- Jan 9th, 2026 5:00 am
Hyperfine Announces First Peer-Reviewed Publication Demonstrating Significant Economic Benefits of Using the Swoop® AI-Powered Portable MRI System in Acute Hospital Care
- Jan 6th, 2026 6:15 am
Hyperfine Announces Regulatory Approval of the Swoop® System in India
- Dec 17th, 2025 6:15 am
Hyperfine Announces FDA Clearance of the First Optive AI™ Software Update with Advanced Diffusion Imaging Capability, Focused on Enhancing Stroke Detection with the Swoop® System
- Dec 15th, 2025 6:15 am
Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference
- Nov 20th, 2025 2:05 pm
Hyperfine Awarded $3.7 Million Grant to Advance Global Brain Health
- Nov 19th, 2025 6:15 am
Hyperfine Inc (HYPR) Q3 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ...
- Nov 13th, 2025 10:04 pm
Hyperfine, Inc. (HYPR) Reports Q3 Loss, Tops Revenue Estimates
- Nov 13th, 2025 4:20 pm
Hyperfine (HYPR) Q3 2025 Earnings Call Transcript
- Nov 13th, 2025 3:39 pm
Hyperfine, Inc. Reports Third Quarter 2025 Financial Results
- Nov 13th, 2025 2:05 pm
Hyperfine, Inc. to Announce Third Quarter 2025 Financial Results on November 13, 2025
- Oct 30th, 2025 2:05 pm
Hyperfine Announces First Patients Enrolled in PRISM PMR to Evaluate the Use of Next-Generation Swoop® System in the Operating Room Setting
- Oct 21st, 2025 6:15 am
Sector Update: Health Care Stocks Softer Late Afternoon
- Oct 16th, 2025 1:51 pm
Hyperfine Announces Pricing of $17.5 Million Public Offering
- Oct 16th, 2025 6:00 am
Hyperfine Announces Proposed Public Offering
- Oct 15th, 2025 2:06 pm
Scroll